triamterene has been researched along with Experimental Neoplasms in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, WJ | 2 |
| Pinedo, HM | 2 |
| Kuiper, CM | 1 |
| Lincke, C | 1 |
| Bamberger, U | 2 |
| Heckel, A | 1 |
| Boven, E | 2 |
| van der Wilt, CL | 1 |
| Feller, N | 1 |
2 other studies available for triamterene and Experimental Neoplasms
| Article | Year |
|---|---|
Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dipyridamole; Doxorubicin; Drug Re | 1994 |
The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Deoxycytidine; Dipyridamole; | 1995 |